drug · small molecule
patient view →UGN-103
Phase 3updated 2mo agoby $URGN UroGen Pharma Ltd.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 32 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that